FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:72 July 6, 1995 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

(Medical Psychiatry. Vol. 2.) Edited by Russell T. Joffe and Joseph R. Calabrese. 244 pp. New York, Marcel Dekker, 1994. $99.75. ISBN 0-8247-9260-2.

Of those with bipolar disorder (formerly known as manic-depressive illness), only half have a good response to lithium carbonate, the first and best-known mood stabilizer, available in the United States since the early 1970s. Thus, the discovery that certain anticonvulsants (valproic acid and carbamazepine) control bipolar (especially manic) symptoms has been one of the more important psychopharmacologic advances of the past 15 years.

This book is a useful update of this area of psychiatry. Because it focuses on mood disorders (and predominantly bipolar mood disorders), it has a narrower scope than a previous book on this topic (S.L. McElroy and . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.